Columbia Laboratories Inc. (CBRX) Stock Quote

Detailed Quote for Columbia Laboratories Inc. (CBRX)

After Hours: $ 0.81

-0.0003 (-0.04%)

Volume: 1.3 k

5:57 PM EST Feb 3, 2012

close 52 Week Information

52 Week High

April 6, 2011

Close: 4.31

52 Week Low

January 23, 2012

Close: 0.6421

Today

Last Price
0.8103

Change $
0.0187

Change %
2.26%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
0.8351

High
0.86

Low
0.80

Prev Close
0.829

Last Trade
4:00

Volume
684.33 k

52 Wk Hi
4.31

52 Wk Low
0.6421

Market Cap
70.71 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
87,267,865

EPS (TTM)
0.08

PE Ratio
10.40

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for Columbia Laboratories Inc. (CBRX)

Sector News | Topic News

News for CBRX

Thu, Feb 02, 2012

2:57 PM

The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in Columbia Laboratories Inc. of Class Action Lawsuit and the Deadline of April 2, 2012 to Seek a Lead Plaintiff Position - Business Wire

1:56 PM

Robbins Umeda LLP Announces an Investigation of Columbia Laboratories, Inc. - Business Wire

12:40 PM

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Columbia Laboratories, Inc. (NASDAQ: CBRX) - Marketwire

Mon, Jan 23, 2012

1:54 PM

Holzer Holzer & Fistel, LLC Announces Investigation into Columbia Laboratories Inc. - Business Wire

10:43 AM

Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc. - Business Wire

Fri, Jan 20, 2012

4:40 PM

FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length - PR Newswire

Wed, Jan 18, 2012

2:54 PM

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Securities Laws Violations by Columbia Laboratories Inc. - Business Wire

Wed, Dec 14, 2011

6:59 AM

Meta-analysis of Five Clinical Trials including Columbia Laboratories' PREGNANT Study Published in American Journal of Obstetrics and Gynecology - Business Wire

Mon, Nov 14, 2011

10:00 PM

Columbia Laboratories Will Present November 15th at Lazard Capital Markets Healthcare Conference - Business Wire

Thu, Nov 10, 2011

9:48 AM

Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA - PR Newswire

Thu, Sep 22, 2011

9:05 AM

Factors Moving Markets, Worldwide View - Equity Research on Columbia Laboratories Inc. and Accuray Incorporated - Marketwire

More News for CBRX >>

Tags for Columbia Laboratories Inc.

Research stocks or mutual funds related to Columbia Laboratories Inc. by keywords or tags. Find companies that have a similar focus to CBRX. The keywords below have been associated to CBRX by either user submission or electronic means.

biotechnology company pharmaceutical market Commercial Physical And Biological Research (8731) pharmaceuticals companies generic pharmaceutical pharmaceutical investment medical product development biotechnology market pharmaceutical research and development drug delivery technologies pharmaceutical manufacturing company female fertility pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharma license progesterone oil low progesterone generic products progesterone cream drug delivery pharmaceutical cro pharma companies pharma consulting clinical trials industry drug delivery market pharmaceutical distributors pharmaceutical labs pharmaceutical development pharmaceutical reports Drugs pregnancy progesterone supplement pharma r&d infertility treatment infertility infertility causes pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation contract pharmaceutical pharmaceutical consulting pharmaceutical industry crinone pharmaceutical studies pharmaceutical advances pharmaceutical distributor pharmaceutical out licensing pharmaceutical business development multinational pharmaceutical companies